Literature DB >> 32011076

Intense focused ultrasound for neck and lower face skin tightening a prospective study.

Or Friedman1, Gila Isman2, Amir Koren2, Hadas Shoshany2, Eli Sprecher2, Ofir Artzi2.   

Abstract

BACKGROUND: Intense focused ultrasound (IFUS) is a Nonablative skin tightening technology with good safety profile, but limited efficacy. Most clinical studies have been performed to evaluate the efficacy of the Ulthera IFUS (Ulthera, Mesa, AZ) in treating redundant skin.
OBJECTIVE: To report our experience with Doublo IFUS (Doublo™, HIRONIC Co.) for treating neck and lower face laxity.
METHODS: This is a prospective study of 43 patients with neck and lower facial laxity treated using IFUS. Response was assessed by two independent dermatologists and graded on a scale of 0 (exacerbation) to 5 (75%-100% improvement). Patient's level of "sagging" and "volume loss", satisfaction and tolerance were documented.
RESULTS: Nine subjects (52.9%) mentioned some improvement. Erythema and edema were acute and transient responses.
CONCLUSION: Ultrasound appears to be a safe modality for facial skin tightening in selected patients with minor skin sagging and no volume discrepancy.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Intense/microfocused ultrasound; skin laxity; skin tightening

Year:  2020        PMID: 32011076     DOI: 10.1111/jocd.13313

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  2 in total

1.  Microfocused Ultrasound with Visualization for Face Slimming: Preliminary Results in Four Women.

Authors:  Talitha Possagno Chaves Bellote; Helio Amante Miot
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-03

2.  Microfocused ultrasound with visualization: Consensus on safety and review of energy-based devices.

Authors:  Tatjana Pavicic; John R Ballard; Tatiana Bykovskaya; Niamh Corduff; Cyro Hirano; Je-Young Park; Alena Saromytskaya; Julia Sevi; Suyan Vasconcelos
Journal:  J Cosmet Dermatol       Date:  2021-12-24       Impact factor: 2.189

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.